Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
Open Access
- 1 May 1989
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 9 (5), 679-685
- https://doi.org/10.1002/hep.1840090504
Abstract
The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed prospectively is compared to that reported in the literature. Asymptomatic elevation of serum aminotransferase levels was detected in approximately one-fourth of the patients, a figure similar to the average of reported cases. The frequency of extrahepatic organ toxicity was increased in patients with elevated levels. Symptomatic “hepatitis” developed in 3% of this series and in less than 1% of cases in the litérature. Evidence of hepatic phospholipidosis and the development of pseudoalcoholic liver injury is most likely due to the biochemical effects of the drug and to possible metabolic idiosyncrasy, respectively. Serial blood enzyme measurements, as recommended by the manufacturer, may offer some protection against the development of more serious liver injury. However, levels of amiodarone may persist in various tissues for weeks to months following withdrawal, and stopping the drug does not guarantee the prompt reversal of any organ toxicity. Accordingly, the risks posed and benefits offered by amiodarone should be carefully weighed prior to discontinuing the drug, as the risk of sudden cardiac death may outweigh the hazards of ongoing hepatic, pulmonary or other toxicity.This publication has 57 references indexed in Scilit:
- AmiodaroneThe New England Journal of Medicine, 1987
- Long-term tolerance of amiodarone treatment for cardiac arrhythmiasThe American Journal of Cardiology, 1986
- Side effects and complications of amiodarone therapyAmerican Heart Journal, 1985
- Steady-State Serum Amiodarone Concentrations: Relationships with Antiarrhythmic Efficacy and ToxicityAnnals of Internal Medicine, 1984
- Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillationThe American Journal of Cardiology, 1983
- Adverse reactions during treatment with amiodarone hydrochloride.BMJ, 1983
- Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.Circulation, 1983
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983
- Amiodarone for control of sustained ventricular tachyarrhythmia: Clinical and electrophysiologic effects in 51 patientsThe American Journal of Cardiology, 1982
- AmiodaroneThe New England Journal of Medicine, 1981